Grupo Espanol de Investigacion en Sarcomas

20 clinical trials · Sponsor

Record	Firm	Date
Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas (NCT05809830)	Grupo Espanol de Investigacion en Sarcomas	2023-05-29
Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor (NCT05146440)	Grupo Espanol de Investigacion en Sarcomas	2021-11-23
Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas (NCT05131386)	Grupo Espanol de Investigacion en Sarcomas	2021-05-28
Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma (NCT04595994)	Grupo Espanol de Investigacion en Sarcomas	2020-09-02
Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST) (NCT04138381)	Grupo Espanol de Investigacion en Sarcomas	2019-08-16
Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK (NCT04181970)	Grupo Espanol de Investigacion en Sarcomas	2019-06-30
Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients (NCT03985722)	Grupo Espanol de Investigacion en Sarcomas	2018-09-21

Every clearance here is in the API, with alerts when new ones post.